Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13

scientific article published on 01 December 2000

Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13 is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0360-3016(00)00782-3
P698PubMed publication ID11121627

P50authorLorraine A. ChampionQ98636626
P2093author name stringG Wong
R Stevens
C Scott
J Fisher
M V Pilepich
J D Gagnon
B Marconi
F Asrari
G M Freedman
P2860cites workPhase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicityQ71727501
Biafine applied on human epidermal wounds is chemotactic for macrophages and increases the IL-1/IL-6 ratioQ74115394
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)1307-1310
P577publication date2000-12-01
P1433published inInternational Journal of Radiation Oncology Biology PhysicsQ2296252
P1476titleRandomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13
P478volume48

Reverse relations

cites work (P2860)
Q57138751Q57138751
Q51754299A Prospective Randomized, Placebo-Controlled Skin Care Study in Women Diagnosed With Breast Cancer Undergoing Radiation Therapy
Q26771210A Review of the Use of Topical Calendula in the Prevention and Treatment of Radiotherapy-Induced Skin Reactions
Q36164303A double-blind randomised controlled trial of a natural oil-based emulsion (Moogoo Udder Cream®) containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer.
Q36453808A phase III trial comparing an anionic phospholipid-based cream and aloe vera-based gel in the prevention of radiation dermatitis in pediatric patients
Q33723980Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years
Q33662782Acute radiation dermatitis in breast cancer patients: challenges and solutions
Q34361075Aloe vera for prevention of radiation-induced dermatitis: a self-controlled clinical trial
Q42368017An Aloe Vera-Based Cosmeceutical Cream Delays and Mitigates Ionizing Radiation-Induced Dermatitis in Head and Neck Cancer Patients Undergoing Curative Radiotherapy: A Clinical Study
Q47322784Are there biologic differences between male and female breast cancer explaining inferior outcome of men despite equal stage and treatment?!
Q33707219Assessment and Comparison of Homogeneity and Conformity Indexes in Step-and-Shoot and Compensator-Based Intensity Modulated Radiation Therapy (IMRT) and Three-Dimensional Conformal Radiation Therapy (3D CRT) in Prostate Cancer
Q89496335Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population
Q92705676Botulinum Neurotoxins and Cancer-A Review of the Literature
Q37288561Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation
Q56981151Calendula officinalis: Potential Roles in Cancer Treatment and Palliative Care
Q34940071Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group.
Q33582645Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection.
Q35439699Conservative procedures in skin reconstitution.
Q57787391Correlation Between Dosimetric Parameters and Acute Dermatitis of Post-operative Radiotherapy in Breast Cancer Patients
Q36550581Correlation between anthropometric parameters and acute skin toxicity in breast cancer radiotherapy patients: a pilot assessment study
Q28972351Current role of modern radiotherapy techniques in the management of breast cancer
Q36228543Dose coverage of axillary level I-III areas during whole breast irradiation with simplified intensity modulated radiation therapy in early stage breast cancer patients
Q92684114Dosimetric comparison between three- and four-dimensional computerised tomography radiotherapy for breast cancer
Q48353206Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer
Q36634391Effect of Bra Use during Radiotherapy for Large-Breasted Women: Acute Toxicity and Treated Heart and Lung Volumes
Q64235946Effectiveness, safety, and economic evaluation of topical application of a herbal ointment, Jaungo, for radiation dermatitis after breast conserving surgery in patients with breast cancer (GREEN study): Study protocol for a randomized controlled tria
Q36687110Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS).
Q37954519Hypofractionated radiation therapy in the treatment of early-stage breast cancer
Q34391739Hypofractionated radiotherapy in the treatment of early breast cancer
Q37720595Intensity-modulated radiation therapy for early-stage breast cancer: is it ready for prime time?
Q46701128Interest of a sterilised anti-burning gel in radiation dermatitis: results of a comparative study
Q37549486Long-term results of forward intensity-modulated radiation therapy for patients with early-stage breast cancer
Q34367737Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4
Q82436653Objective Assessment of Dermatitis Following Post-operative Radiotherapy in Patients with Breast Cancer Treated with Breast-conserving Treatment
Q44828020Outcomes research in cancer clinical trial cooperative groups: the RTOG model
Q79329677Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy
Q37175665Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy
Q43715573Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy
Q35999596Photobiomodulation for the management of radiation dermatitis: the DERMIS trial, a pilot study of MLS(®) laser therapy in breast cancer patients
Q30613382Post mastectomy linac IMRT irradiation of chest wall and regional nodes: dosimetry data and acute toxicities
Q38110447Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia
Q31149109Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials
Q37353578Prone whole-breast irradiation using three-dimensional conformal radiotherapy in women undergoing breast conservation for early disease yields high rates of excellent to good cosmetic outcomes in patients with large and/or pendulous breasts
Q34035512Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature
Q89631380Protective effects of doxepin cream on radiation dermatitis in breast cancer: A single arm double-blind randomized clinical trial
Q81312385Quality of life of women treated with radiotherapy for breast cancer
Q46701133Radiation induced skin reactions
Q60937732Radiation-induced skin reactions: mechanism and treatment
Q45843318Radiodermatitis prevention with sucralfate in breast cancer: fundamental and clinical studies.
Q27310815Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models.
Q57755658Role and mechanism of radiological protection cream in treating radiation dermatitis in rats
Q35553856Symptom Control
Q37345699Symptom management in premenopausal patients with breast cancer
Q33817013The clinical features and pathophysiology of acute radiation dermatitis in patients receiving tomotherapy
Q34482444The effect of laughter therapy on radiation dermatitis in patients with breast cancer: a single-blind prospective pilot study
Q55365327The incidence of postoperative radiotherapy-induced acute dermatitis in breast cancer and its influencing factors for Chinese women.
Q28244712The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline
Q34325462The safety and efficacy of EGF-based cream for the prevention of radiotherapy-induced skin injury: results from a multicenter observational study
Q38052024Topical agent therapy for prevention and treatment of radiodermatitis: a meta-analysis
Q37604785Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial
Q82067637Topical silver sulfadiazine for the prevention of acute dermatitis during irradiation for breast cancer
Q36046400Topical use of olive oil preparation to prevent radiodermatitis: results of a prospective study in nasopharyngeal carcinoma patients
Q38852495Trolamine emulsion for the prevention of radiation dermatitis in patients with squamous cell carcinoma of the head and neck
Q55350916Use of trolamine to prevent and treat acute radiation dermatitis: a systematic review and meta-analysis.
Q34418407Validation of the cell cycle G(2) delay assay in assessing ionizing radiation sensitivity and breast cancer risk
Q36133827Volumetric modulated arc therapy for synchronous bilateral whole breast irradiation - A case study

Search more.